位置:首页 > 蛋白库 > PARP1_XENLA
PARP1_XENLA
ID   PARP1_XENLA             Reviewed;         998 AA.
AC   P31669;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   03-AUG-2022, entry version 131.
DE   RecName: Full=Poly [ADP-ribose] polymerase 1;
DE            Short=PARP-1;
DE            EC=2.4.2.30 {ECO:0000250|UniProtKB:P09874};
DE   AltName: Full=ADP-ribosyltransferase diphtheria toxin-like 1;
DE            Short=ARTD1;
DE   AltName: Full=DNA ADP-ribosyltransferase PARP1 {ECO:0000250|UniProtKB:P09874};
DE            EC=2.4.2.- {ECO:0000250|UniProtKB:P09874};
DE   AltName: Full=NAD(+) ADP-ribosyltransferase 1;
DE            Short=ADPRT 1;
DE   AltName: Full=Poly[ADP-ribose] synthase 1;
DE   AltName: Full=Protein poly-ADP-ribosyltransferase PARP1 {ECO:0000250|UniProtKB:P09874};
DE            EC=2.4.2.- {ECO:0000250|UniProtKB:P09874};
DE   Flags: Fragment;
GN   Name=parp1;
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC   Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX   NCBI_TaxID=8355;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Ovary;
RA   Saulier-Le Drean B.M.;
RL   Thesis (1992), University of Rennes, France.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 742-876.
RX   PubMed=8503897; DOI=10.1006/bbrc.1993.1598;
RA   Ozawa Y., Uchida K., Uchida M., Ami Y., Kushida S., Okada N., Miwa M.;
RT   "Isolation of cDNAs encoding the catalytic domain of poly(ADP-ribose)
RT   polymerase from Xenopus laevis and cherry salmon using heterologous
RT   oligonucleotide consensus sequences.";
RL   Biochem. Biophys. Res. Commun. 193:119-125(1993).
CC   -!- FUNCTION: Poly-ADP-ribosyltransferase that mediates poly-ADP-
CC       ribosylation of proteins and plays a key role in DNA repair. Mediates
CC       glutamate, aspartate, serine or tyrosine ADP-ribosylation of proteins:
CC       the ADP-D-ribosyl group of NAD(+) is transferred to the acceptor
CC       carboxyl group of target residues and further ADP-ribosyl groups are
CC       transferred to the 2'-position of the terminal adenosine moiety,
CC       building up a polymer with an average chain length of 20-30 units.
CC       Serine ADP-ribosylation of proteins constitutes the primary form of
CC       ADP-ribosylation of proteins in response to DNA damage. Mainly mediates
CC       glutamate and aspartate ADP-ribosylation of target proteins in absence
CC       of HPF1. Following interaction with HPF1, catalyzes serine ADP-
CC       ribosylation of target proteins; HPF1 conferring serine specificity by
CC       completing the PARP1 active site. Also catalyzes tyrosine ADP-
CC       ribosylation of target proteins following interaction with HPF1. PARP1
CC       initiates the repair of DNA breaks: recognizes and binds DNA breaks
CC       within chromatin and recruits HPF1, licensing serine ADP-ribosylation
CC       of target proteins, such as histones, thereby promoting decompaction of
CC       chromatin and the recruitment of repair factors leading to the
CC       reparation of DNA strand breaks. In addition to proteins, also able to
CC       ADP-ribosylate DNA: catalyzes ADP-ribosylation of DNA strand break
CC       termini containing terminal phosphates and a 2'-OH group in single- and
CC       double-stranded DNA, respectively. {ECO:0000250|UniProtKB:P09874}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NAD(+) + (ADP-D-ribosyl)n-acceptor = nicotinamide + (ADP-D-
CC         ribosyl)n+1-acceptor + H(+).; EC=2.4.2.30;
CC         Evidence={ECO:0000250|UniProtKB:P09874};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-seryl-[protein] + NAD(+) = H(+) + nicotinamide + O-(ADP-D-
CC         ribosyl)-L-seryl-[protein]; Xref=Rhea:RHEA:58232, Rhea:RHEA-
CC         COMP:9863, Rhea:RHEA-COMP:15091, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17154, ChEBI:CHEBI:29999, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:142556; Evidence={ECO:0000250|UniProtKB:P09874};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58233;
CC         Evidence={ECO:0000250|UniProtKB:P09874};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-aspartyl-[protein] + NAD(+) = 4-O-(ADP-D-ribosyl)-L-
CC         aspartyl-[protein] + nicotinamide; Xref=Rhea:RHEA:54424, Rhea:RHEA-
CC         COMP:9867, Rhea:RHEA-COMP:13832, ChEBI:CHEBI:17154,
CC         ChEBI:CHEBI:29961, ChEBI:CHEBI:57540, ChEBI:CHEBI:138102;
CC         Evidence={ECO:0000250|UniProtKB:P09874};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54425;
CC         Evidence={ECO:0000250|UniProtKB:P09874};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-glutamyl-[protein] + NAD(+) = 5-O-(ADP-D-ribosyl)-L-
CC         glutamyl-[protein] + nicotinamide; Xref=Rhea:RHEA:58224, Rhea:RHEA-
CC         COMP:10208, Rhea:RHEA-COMP:15089, ChEBI:CHEBI:17154,
CC         ChEBI:CHEBI:29973, ChEBI:CHEBI:57540, ChEBI:CHEBI:142540;
CC         Evidence={ECO:0000250|UniProtKB:P09874};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58225;
CC         Evidence={ECO:0000250|UniProtKB:P09874};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-tyrosyl-[protein] + NAD(+) = H(+) + nicotinamide + O-(ADP-D-
CC         ribosyl)-L-tyrosyl-[protein]; Xref=Rhea:RHEA:58236, Rhea:RHEA-
CC         COMP:10136, Rhea:RHEA-COMP:15092, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17154, ChEBI:CHEBI:46858, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:142557; Evidence={ECO:0000250|UniProtKB:P09874};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58237;
CC         Evidence={ECO:0000250|UniProtKB:P09874};
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P09874}. Nucleus,
CC       nucleolus {ECO:0000250|UniProtKB:P09874}. Chromosome
CC       {ECO:0000250|UniProtKB:P09874}. Note=Localizes to sites of DNA damage.
CC       {ECO:0000250|UniProtKB:P09874}.
CC   -!- DOMAIN: The N-terminal disordered region does not act as a key DNA-
CC       binding domain. The WGR and PARP catalytic domains function together to
CC       recruit PARP1 to sites of DNA breaks. The N-terminal disordered region
CC       is only required for activation on specific types of DNA damage.
CC       {ECO:0000250|UniProtKB:Q9UGN5}.
CC   -!- DOMAIN: The WGR domain bridges two nucleosomes, with the broken DNA
CC       aligned in a position suitable for ligation. The bridging induces
CC       structural changes in PARP1 that signal the recognition of a DNA break
CC       to the catalytic domain of PARP1, promoting HPF1 recruitment and
CC       subsequent activation of PARP1, licensing serine ADP-ribosylation of
CC       target proteins. {ECO:0000250|UniProtKB:Q9UGN5}.
CC   -!- PTM: Poly-ADP-ribosylated on glutamate and aspartate residues by
CC       autocatalysis. {ECO:0000250|UniProtKB:P09874}.
CC   -!- SIMILARITY: Belongs to the ARTD/PARP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z12139; CAA78126.1; -; mRNA.
DR   EMBL; D13810; BAA02966.1; -; mRNA.
DR   PIR; S31735; S31735.
DR   AlphaFoldDB; P31669; -.
DR   SMR; P31669; -.
DR   IntAct; P31669; 1.
DR   Proteomes; UP000186698; Genome assembly.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:1990404; F:NAD+-protein ADP-ribosyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:1990966; P:ATP generation from poly-ADP-D-ribose; ISS:UniProtKB.
DR   GO; GO:0030592; P:DNA ADP-ribosylation; ISS:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0018424; P:peptidyl-glutamic acid poly-ADP-ribosylation; ISS:UniProtKB.
DR   GO; GO:0018312; P:peptidyl-serine ADP-ribosylation; ISS:UniProtKB.
DR   GO; GO:1905168; P:positive regulation of double-strand break repair via homologous recombination; ISS:UniProtKB.
DR   GO; GO:0006471; P:protein ADP-ribosylation; ISS:UniProtKB.
DR   GO; GO:0070213; P:protein auto-ADP-ribosylation; ISS:UniProtKB.
DR   GO; GO:0070212; P:protein poly-ADP-ribosylation; ISS:UniProtKB.
DR   Gene3D; 1.20.142.10; -; 1.
DR   Gene3D; 2.20.25.630; -; 1.
DR   Gene3D; 3.30.1740.10; -; 2.
DR   Gene3D; 3.40.50.10190; -; 1.
DR   InterPro; IPR001357; BRCT_dom.
DR   InterPro; IPR036420; BRCT_dom_sf.
DR   InterPro; IPR012982; PADR1.
DR   InterPro; IPR038650; PADR1_dom_sf.
DR   InterPro; IPR008288; PARP.
DR   InterPro; IPR012317; Poly(ADP-ribose)pol_cat_dom.
DR   InterPro; IPR004102; Poly(ADP-ribose)pol_reg_dom.
DR   InterPro; IPR036616; Poly(ADP-ribose)pol_reg_dom_sf.
DR   InterPro; IPR036930; WGR_dom_sf.
DR   InterPro; IPR008893; WGR_domain.
DR   InterPro; IPR001510; Znf_PARP.
DR   InterPro; IPR036957; Znf_PARP_sf.
DR   Pfam; PF00533; BRCT; 1.
DR   Pfam; PF08063; PADR1; 1.
DR   Pfam; PF00644; PARP; 1.
DR   Pfam; PF02877; PARP_reg; 1.
DR   Pfam; PF05406; WGR; 1.
DR   Pfam; PF00645; zf-PARP; 2.
DR   PIRSF; PIRSF000489; NAD_ADPRT; 1.
DR   SMART; SM00292; BRCT; 1.
DR   SMART; SM01335; PADR1; 1.
DR   SMART; SM00773; WGR; 1.
DR   SMART; SM01336; zf-PARP; 2.
DR   SUPFAM; SSF142921; SSF142921; 1.
DR   SUPFAM; SSF47587; SSF47587; 1.
DR   SUPFAM; SSF52113; SSF52113; 1.
DR   PROSITE; PS50172; BRCT; 1.
DR   PROSITE; PS51060; PARP_ALPHA_HD; 1.
DR   PROSITE; PS51059; PARP_CATALYTIC; 1.
DR   PROSITE; PS00347; PARP_ZN_FINGER_1; 2.
DR   PROSITE; PS50064; PARP_ZN_FINGER_2; 2.
DR   PROSITE; PS51977; WGR; 1.
PE   2: Evidence at transcript level;
KW   ADP-ribosylation; Chromosome; DNA damage; DNA repair; DNA-binding;
KW   Glycosyltransferase; Metal-binding; NAD; Nucleotidyltransferase; Nucleus;
KW   Reference proteome; Repeat; Transferase; Zinc; Zinc-finger.
FT   CHAIN           <1..998
FT                   /note="Poly [ADP-ribose] polymerase 1"
FT                   /id="PRO_0000211324"
FT   DOMAIN          369..460
FT                   /note="BRCT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   DOMAIN          525..621
FT                   /note="WGR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01321"
FT   DOMAIN          645..762
FT                   /note="PARP alpha-helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00398"
FT   DOMAIN          771..997
FT                   /note="PARP catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00397"
FT   ZN_FING         <1..78
FT                   /note="PARP-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00264"
FT   ZN_FING         99..189
FT                   /note="PARP-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00264"
FT   REGION          185..211
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          348..370
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          357..507
FT                   /note="Automodification domain"
FT                   /evidence="ECO:0000250|UniProtKB:P09874"
FT   REGION          471..510
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           193..195
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:P09874"
FT   MOTIF           207..212
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:P09874"
FT   COMPBIAS        348..362
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        490..510
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        971
FT                   /note="For poly [ADP-ribose] polymerase activity"
FT                   /evidence="ECO:0000250|UniProtKB:P09874"
FT   BINDING         845..847
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UGN5"
FT   BINDING         854
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UGN5"
FT   BINDING         861
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UGN5"
FT   BINDING         887
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UGN5"
FT   MOD_RES         391
FT                   /note="PolyADP-ribosyl glutamic acid"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         397
FT                   /note="PolyADP-ribosyl glutamic acid"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         419
FT                   /note="PolyADP-ribosyl glutamic acid"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         428
FT                   /note="PolyADP-ribosyl glutamic acid"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         429
FT                   /note="PolyADP-ribosyl glutamic acid"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         445
FT                   /note="PolyADP-ribosyl glutamic acid"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         447
FT                   /note="PolyADP-ribosyl glutamic acid"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         454
FT                   /note="PolyADP-ribosyl glutamic acid"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         467
FT                   /note="PolyADP-ribosyl glutamic acid"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         471
FT                   /note="PolyADP-ribosyl glutamic acid"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         477
FT                   /note="PolyADP-ribosyl glutamic acid"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         495
FT                   /note="PolyADP-ribosyl glutamic acid"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         496
FT                   /note="PolyADP-ribosyl glutamic acid"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         503
FT                   /note="PolyADP-ribosyl glutamic acid"
FT                   /evidence="ECO:0000255"
FT   CONFLICT        746
FT                   /note="Q -> E (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   NON_TER         1
SQ   SEQUENCE   998 AA;  111126 MW;  F5A25E4A3366BAE7 CRC64;
     AKSGRASCKK CGDNIAKESL GLAIMVQSPM FDGKVPHWHH YSCFWKRARV LSQGDIYGYT
     ELRWEDQEMI KKAIETGGAA AGAGGDSKGG KGEMTLNDFA AEYAKSNRSA CKGCEQKIEK
     GQIRISKKSV DVERPQLGMI DRWYHPDCFV SSREELDFLP SYSASQLKGF TILSAEDKDS
     LKKKLPAVKN EGKRKADEVD GHSAATKKKI KKEKEKESKL EKLLKEQTEL IWHIKDELKK
     VCSTNDLKEL LIANKQQVPS GETNIVDRVS DGMAFGALLP CEECSGQFVF KGDAYYCTGD
     LSAWTKCVAK TQTPNRKDWV TPKEFHEIPY LKKFKFKRHD RAFPPCAAPT PISPPAAPEP
     KPTVEETFPE GKPLTNTKVL LIGKLSKNKD EVKTLIEGLG GKVAGSAHKA NLCISTNKEV
     KKMSKKMEEV KAANVRVVSD DFLKEVESGK SVQELLSQFG ISSWGAEIKQ EAVQPTEKQP
     SSGPVAGKSS GKVKEEKGSN KSEKKMKLTV KGGAAIDPDS ELEDSCHVLE TGGKIFSATL
     GLVDITRGTN SYYKLQLIEH DRDSRYWVFR SWGRVGTVIG SKKLEEMSSK EDAIEHFLNL
     YQDKTGNAWH SPNFTKYPKK FYPLEIDYGQ EEDVVKKLSV GAGTKSKLAK PVQELIKLIF
     DVESMKKAMV EFEIDLQKMP LGKLSKRQIQ SAYSILSQVQ QAVSESLSEA RLLDLSNQFY
     TLIPHDFGMK KPPLLNNLEY IQAKVQMLDN LLDIEVAYSL LRGGADDGEK DPIDVKYEKI
     KTDIKVVAKD SEESRIICDY VKNTHADTHN AYDLEVLEIF KIDREGEYQR YKPFKQLHNR
     QLLWHGSRTT NFAGILSQGL RIAPPEAPVT GYMFGKGIYF ADMVSKSANY CHAMPGSPIG
     LILLGEVALG NMHELKAASQ ITKLPKGKHS VKGLGRTAPD PSATVQLDGV DVPLGKGTSA
     NISDTSLLYN EYIVYDIAQV NLKYLLKLKF NYKGGMMW
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024